Diploma PLC (LSE: DPLM) is a global group of businesses supplying specialised technical products and services. The company operates through three sectors: Controls, Seals, and Life Sciences, each with a strong niche market position. Diploma has a proven track record of value-creating acquisitions, disciplined capital allocation, and consistent organic growth.
Recent results show accelerating organic revenue growth, with the company benefiting from structural demand in healthcare, aerospace, and automation. Management has guided to further margin improvement as it integrates recent acquisitions and drives operational efficiencies. The balance sheet is strong, with net debt at comfortable levels and ample liquidity for future deals.
We believe Diploma is well-positioned to deliver high-single-digit organic growth plus accretive M&A, leading to mid-teens earnings per share growth over the next few years. The current valuation is reasonable relative to its growth and quality, and we see potential for multiple expansion as the market recognises the resilience and growth profile of the business.
Catalysts over the next 12 months:
- Continued organic growth acceleration, particularly in Life Sciences and Controls.
- Further value-accretive acquisitions, funded by strong cash generation.
- Margin expansion from operational leverage and integration of recent deals.
Key risks:
- Economic downturn impacting end markets, particularly industrial and construction.
- Integration risks from M&A or a large acquisition that fails to deliver expected synergies.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always conduct your own research and consider your financial position before investing.